Stock Earnings

Question 1

Mersana Therapeutics Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Mersana Therapeutics Inc 的总资产为 $144，净loss为 $-69

Question 2

MRSN 的关键财务比率是什么？

Accepted Answer

Mersana Therapeutics Inc 的流动比率是 0.93，净利 margin 为 -172.5，每股销售为 $8.16。

Question 3

Mersana Therapeutics Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Mersana Therapeutics Inc largest revenue segment is Antibody-drug Conjugates, at a revenue of 40,497,000 in the most earnings release.For geography, United States is the primary market for Mersana Therapeutics Inc, at a revenue of 40,497,000.

Question 4

Mersana Therapeutics Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Mersana Therapeutics Inc 的净loss为 $-69

Question 5

Mersana Therapeutics Inc 有负债吗？

Accepted Answer

yes，Mersana Therapeutics Inc 的负债为 154

Question 6

Mersana Therapeutics Inc 的流通股有多少？

Accepted Answer

Mersana Therapeutics Inc 的总流通股为 4.62

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	34	40	36	26	0	0
Revenue Growth (YoY)	17%	11%	38%	--	--	-100%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	35	40	59	56	36	21
Research & Development	71	73	148	173	132	67
Operating Expenses	106	113	207	230	168	88
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-73	-68	-171	-204	-170	-88
Income Tax Expense	--	0	--	--	--	--
Net Income	-74	-69	-171	-204	-170	-88
Net Income Growth	-28.99%	-60%	-16%	20%	93%	214%
Shares Outstanding (Diluted)	4.98	4.9	4.64	3.74	2.82	2.45
Shares Change (YoY)	2%	6%	24%	33%	15%	41%
EPS (Diluted)	-14.84	-14.11	-36.96	-54.51	-60.23	-35.8
EPS Growth	-31%	-62%	-32%	-10%	68%	121%
Free Cash Flow	-79	-82	-171	-51	-140	-75
Free Cash Flow Per Share	-15.84	-16.72	-36.81	-13.61	-49.58	-30.49
Gross Margin	--	--	--	--	--	--
Operating Margin	-208.82%	-182.5%	-472.22%	-780.76%	0%	0%
Profit Margin	-217.64%	-172.5%	-475%	-784.61%	0%	0%
Free Cash Flow Margin	-232.35%	-204.99%	-475%	-196.15%	0%	0%
EBITDA	-70	-72	-169	-203	-168	-87
EBITDA Margin	-205.88%	-180%	-469.44%	-780.76%	0%	0%
D&A For EBITDA	1	1	1	0	0	1
EBIT	-71	-73	-170	-203	-168	-88
EBIT Margin	-208.82%	-182.5%	-472.22%	-780.76%	0%	0%
Effective Tax Rate	--	0%	--	--	--	--

Mersana Therapeutics Inc (MRSN) Price

MRSN Stock Price Chart

MRSN Income

Follow-Up Questions